- Details
-
Category: Contracts Research and Manufacturing
Fortis Clinical Research (FCRL), a Fortis Religare group company which so far functioning as an exclusive partner for Ranbaxy is venturing into full service clinical research. Currently, the global clinical research market is estimated at US$64 billion. Full service clinical research will include trials from phase I to phase III. Fortis has 48 hospitals across the country, while Super Religare Laboratories has 200 laboratories which will bring synergy in a full service clinical trials service. It has enjoyed patronage of pharma majors like Torrent, Unichem, IPCA, Ind-Swift, Panacea etc.,
